Enveda

We're #hiring a new Supply Chain Associate in Hyderabad, Telangana. Apply today or share this post with your network.

We're #hiring a new Senior Research Associate, Invivo Pharmacology in Hyderabad, Telangana. Apply today or share this post with your network.

The promise of AI to discover medicines that will fundamentally change how we live is happening NOW. Enveda is using AI to analyze biology and chemistry at an unprecedented resolution, unlocking new possibilities for drug discovery that have the potential to transform health and humanity. Don't miss Enveda's Chief Execution Officer, Dan Wee, PhD , speaking at the inaugural LEAP East conference in Hong Kong next week. July 9 | 10:10 - 10:40 AM The Next Frontier for Therapeutics: AI Driven Innovation | Orbital Stage | LEAP East Details in the comments. #DrugDiscovery #AI #Biotech

We're #hiring a new CMC Director - Drug Product in United States. Apply today or share this post with your network.

How has Enveda defied convention in both AI and biotech to quickly become a clinical-stage company with multiple drugs in patients? Our Founder & CEO, Viswa Colluru, PhD, recently sat down with Akshay Rai at Premji Invest - US, a high-conviction investor who has backed Enveda across multiple rounds, to discuss the strategies that have shaped Enveda's approach. Some of the topics they explore: On AI: Why applying AI to the same target-first playbook may not be enough to change drug discovery's 90% failure rate. On speed and efficiency: How Enveda built an integrated prediction, validation, and iteration loop that dramatically accelerates the path from hit to candidate. On defensibility: Why the most valuable medicines may be the ones that reveal entirely new biology. On vision: What it might take to build a generational pharma company rather than optimize for a single-asset outcome. Watch the full conversation — link in comments. #Biotech #DrugDiscovery #AI

The next generation of medicines requires us to rethink how we discover, develop, fund, and deliver innovation. At #BIO2026, Enveda leaders Founder & CEO Viswa Colluru, PhD, Chief Scientific Officer Hannah Gordon, PhD, MSCI, and SVP of Capital Formation & Global Partnerships Bigyan R. Bista, PhD will help shape the conversation around some of the most important questions facing our industry. • What if we could compress the timeline from scientific discovery to patient impact? • What does it take to build investor conviction around an ambitious vision in today's market? • How are AI and nature unlocking signals that have remained hidden for centuries? • What global partnerships are needed to bring breakthrough medicines faster to patients in need? Connect with us at #BIO2026. Link in the comments. #DrugDiscovery #Biotech #AI

We're #hiring a new VP, Head of Regulatory in United States. Apply today or share this post with your network.

We're #hiring a new Sr. ADME and Quantitative Pharmacology Director in United States. Apply today or share this post with your network.

At today's pace, humanity will wait more than 500 years for every known disease to have a cure. What would our industry do differently if we acted as though we had 50? At #BIO2026, Enveda Founder & CEO Viswa Colluru, PhD will join biotech leaders for a private event on what it will take to dramatically compress the timeline from scientific discovery to patient impact. The conversation will explore where AI can meaningfully accelerate drug discovery, the barriers slowing progress today, and what the future could look like if our industry truly optimized for getting medicines to patients faster. June 23 | 6:00 - 9:00 PM: From 500 years to 50 - accelerating cures | Alpha Hours / 01 Details in the comments. #DrugDiscovery #Biotech #AI